Difficulty: Medium
Average Score: 93%
Practice
A 43-year-old man with a history of peptic ulcer disease has developed hypersensitivity to HÔéé blockers. He now complains of worsening of his dyspepsia. Physical examination reveals mild tenderness on the midepigastric region. If misoprostol is prescribed to this patient, which of the following mechanisms of action would be most plausible for this agent?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Enhance mucosal resistance. Misoprostol is a synthetic prostaglandin E1 analog that acts by enhancing mucosal resistance to injury in the gastrointestinal tract. It helps protect the stomach lining from damage caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and other irritants.
Option B) Inhibition of gastrin secretion is incorrect because misoprostol does not directly affect gastrin levels. Option C) Inhibition of proton pump secretion is incorrect as misoprostol does not inhibit proton pump activity. Option D) Inhibition of somatostatin release is also incorrect as misoprostol does not affect somatostatin release.
Educationally, understanding the mechanism of action of misoprostol is crucial in pharmacology across the lifespan. Misoprostol is commonly used to prevent NSAID-induced peptic ulcers and is especially important in patients with a history of peptic ulcer disease who cannot tolerate HÔéé blockers. By enhancing mucosal resistance, misoprostol helps protect the stomach lining and reduce the risk of ulcer formation, making it a valuable therapeutic option in such cases.
Option B) Inhibition of gastrin secretion is incorrect because misoprostol does not directly affect gastrin levels. Option C) Inhibition of proton pump secretion is incorrect as misoprostol does not inhibit proton pump activity. Option D) Inhibition of somatostatin release is also incorrect as misoprostol does not affect somatostatin release.
Educationally, understanding the mechanism of action of misoprostol is crucial in pharmacology across the lifespan. Misoprostol is commonly used to prevent NSAID-induced peptic ulcers and is especially important in patients with a history of peptic ulcer disease who cannot tolerate HÔéé blockers. By enhancing mucosal resistance, misoprostol helps protect the stomach lining and reduce the risk of ulcer formation, making it a valuable therapeutic option in such cases.